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Abstract
Background: Prostate cancer is the single most prevalent cancer in US men whose gold standard of diagnosis is
histologic assessment of biopsies. Manual assessment of stained tissue of all biopsies limits speed and accuracy in
clinical practice and research of prostate cancer diagnosis. We sought to develop a fully-automated multimodal
microscopy method to distinguish cancerous from non-cancerous tissue samples.
Methods: We recorded chemical data from an unstained tissue microarray (TMA) using Fourier transform infrared
(FT-IR) spectroscopic imaging. Using pattern recognition, we identified epithelial cells without user input. We fused
the cell type information with the corresponding stained images commonly used in clinical practice. Extracted
morphological features, optimized by two-stage feature selection method using a minimum-redundancy-maximal-
relevance (mRMR) criterion and sequential floating forward selection (SFFS), were applied to classify tissue samples
as cancer or non-cancer.
Results: We achieved high accuracy (area under ROC curve (AUC) >0.97) in cross-validations on each of two data
sets that were stained under different conditions. When the classifier was trained on one data set and tested on
the other data set, an AUC value of ~0.95 was observed. In the absence of IR data, the performance of the same
classification system dropped for both data sets and between data sets.
Conclusions: We were able to achieve very effective fusion of the information from two different images that
provide very different types of data with different characteristics. The method is entirely transparent to a user and
does not involve any adjustment or decision-making based on spectral data. By combining the IR and optical data,
we achieved high accurate classification.
Background
Prostate cancer
Prostate cancer (PCa) is the single most prevalent cancer
in US men, accounting for one-third of non-skin cancer
diagnoses every year [1]. Screening for the disease is
widespread and for almost a million cases a year [2-4], a
biopsy is conducted to detect or rule out cancer [3].
Manually-conducted histologic assessment of tissue upon
biopsy forms the definitive diagnosis of PCa [5]. This
need places a large demand on pathology services and
manual examination limits speed and throughput. Histo-
logic assessment is also critical to scientific progress as it
is often the basis for research studies. Alternative meth-
ods for histologic recognition can greatly aid in alleviat-
ing workloads, assuring quality control and reducing
costs [6]. There is no straightforward way, however, to
aid pathology in this task and no clinical instrument is
available for routine use. Hence, high-throughput, auto-
mated and objective tools for prostate pathology - both
in clinical practice and in research - are needed.
Optical microscopy and automated PCa detection
Since the tissue does not have appreciable contrast in opti-
cal brightfield microscopy (Figure 1A), tissue samples are
commonly stained using hematoxylin and eosin (H&E)
prior to review by a pathologist. The stain is specific in
limited terms - staining protein-rich regions pink and
nucleic acid-rich regions of the tissue blue (Figure 1B).
A pathologist is trained to recognize, from a stained tissue
sample, the morphology and local architecture of glands
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The specific cell type that is used to recognize glandular
structures is the epithelial sub-type. In prostatic carci-
noma, which comprises more than 95% of prostate cancers
[5], the cells of interest are epithelial cells [7]. Epithelial
cells line 3D ducts in intact tissue and, hence, appear as
cells lining empty circular regions (lumens) in images of
histologic sections. Patterns of distortions of lumen
appearance and spacing, as well as the arrangement of
epithelial cells relative to lumens, have been characterized
to indicate cancer and characterize its severity (Gleason
grade) [8,9]. The greater the distortion and loss of regular
structure, the worse (higher grade) the cancer.
Recognizing structural distortions indicative of disease
is a manual pattern recognition process that matches
patterns in the tissue sample to standard patterns. Man-
ual examination is powerful in that humans can recog-
nize disease from a wide spectrum of normal and
disease states, can overcome confounding artifacts,
detect unusual cases and even recognize deficiencies in
diagnoses. Manual examination, unfortunately, is time-
consuming and leads routinely to variability in grading
disease [8]. Computer-aided recognition of disease sam-
ples and grade patterns [10], hence, holds the potential
for more accurate, reproducible and automated diag-
noses [11,12]. Unfortunately, tissue samples stain vari-
ably in populations due to biological diversity, with
variations in stain composition, processing conditions
and histotechnologists. The net result confounds auto-
mated image analysis and human-competitive recogni-
tion of cancer has not been automated for routine use.
A robust means of automatically detecting epithelium
and correlating its spatial patterns to determining cancer
presence is highly desirable but yet unsolved.
Several efforts have been made to develop automated
systems for the diagnosis and grading of microscopic
prostate images. These include methods to identify dis-
t i n c tt i s s u ec o m p o s i t i o n s[ 1 3 , 1 4 ]a sw e l la ss e v e r a l
methods for automatic grading [15-23]. The majority
of these methods have extracted texture and/or
morphological features to characterize tissue samples.
Histologic objects such as nuclei, lumen, or gland have
been mainly used to extract morphological features
[15,16,20-22,24,25]. Fourier Transform [17], Wavelet
Transform [18,19,22], and Fractal Analysis [22,23] have
been the techniques commonly used to obtain texture
features. In addition to these features, color [22] and
graph-based [20] features have also been used. A num-
ber of classifiers have been tested on various features
and data sets, although the choice of classifiers seems
to have been less significant than the feature extraction
step [22,23].
Despite the above-mentioned lines of progress in
automated diagnosis, an important concern is that the
varying properties of images, due to acquisition settings
[19,25] and staining [26], may affect the classification
results substantially. Although the issue of image varia-
tion by different acquisition settings has been addressed
in [19,25], to the best of our knowledge, no previous
method has been validated across data sets under differ-
ent staining conditions.
A major roadblock has been the limited information
present in the data. For example, different cell types and
morphologies are recognized by recognizing colors for
empty space (usually close to white), apical portion of
epithelial cells (usually pink) and the basal layer of
epithelial cells (usually pink-dark blue). Immunohisto-
chemical probes add useful information to diagnostic
processes and are effective in understanding specific
aspects of the disease, e.g. loss of basement membrane.
For routine diagnostic pathology, however, the use of
such molecular stains is expensive, time-consuming and
does not actually address the need for an operator-free
method. Additional molecular data is now available
using label-free spectroscopic imaging, also known as
chemical imaging [27].
Chemical imaging and automated histologic classification
Prostatic epithelial cells (and other cell types) [28] have
recently been automatically recognized using a novel
form of chemical imaging based on mid-infrared (IR)
spectroscopy. Fourier transform infrared (FT-IR) spec-
troscopic imaging provides non-perturbing imaging by
combining the spatial specificity of optical microscopy
with the molecular selectivity of vibrational spectro-
scopy. Mid-IR spectral frequencies are resonant with the
fundamental vibrational mode frequencies in molecules;
hence, the IR absorption spectrum at each pixel is a
quantitative record of composition [29]. FT-IR imaging
has been successfully applied to various biological and
Figure 1 Staining allows visualization of tissue features.( a )a n
unstained image has little contrast while (b) the application of H&E
stain highlights nucleic acid-rich regions as blue and protein-rich
regions at pink. (c) structure of a prostate gland. It is notable that
the stain is universal in that it is not diagnostic of cell type or
disease. The stain serves only to provide contrast that is
subsequently used by a human to recognize cell types and
diagnose disease.
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concentrations [30,31] and structure [32,33], characteriz-
ing cell components [34] and cancer diagnosis [35-37].
In particular, the spectral patterns of different cell types
being different, computerized pattern recognition can be
used to assign each pixel into constituent cell types. The
final result of recording data and mathematical analysis
is images of tissue that are color coded for cell type.
The process is illustrated in Figure 2. The approach has
been used by a number of groups and is summarized in
recent edited volumes [38,39]. Since the numerical algo-
rithms are automated, quantification of accuracy and
statistical confidence in results is facile [40].
The above approach has been extensively validated in
providing histologic recognition using tissue samples
from over 1000 patients and tens of millions of pixels
using tissue microarrays (TMAs). TMAs consist of mul-
tiple tissue samples of a size that assures representative
sampling and allow high throughput experimentation in
an efficient manner. For this manuscript, we examined
two independent data sets from prostate tissue microar-
rays that were subjected to chemical imaging and histo-
logic classification as outlined above. Images of the data
are shown in Figure 2.
While we expected the chemical imaging approach to
prove useful in histologic analysis of prostate tissue, its
relationship to the existing clinical practice of using
H&E stained tissue in PCa diagnosis was not clear
a priori. Hence, we sought to examine whether a combi-
nation of the two techniques (i.e., optical microscopy
Figure 2 IR imaging data and its use in histologic classification. (Upper row) IR imaging data (b) is acquired for an unstained tissue section
(a). The data is then classified into cell types and a classified image (c) is obtained. The colors indicate cell types in a histologic model of
prostate tissue. This method is robust and applied to hundreds of tissue samples using the tissue microarray (TMA) format. (Lower row) H&E
(d) and IR classified (e) images of a part of the TMAs used.
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vide high accuracy diagnoses that could otherwise not
be achieved using H&E images alone.
Overview of this work
We develop a new fully-automated method to classify
cancer versus non-cancer prostate tissue samples. The
classification algorithm uses morphological features -
geometric properties of epithelial cells/nuclei and
lumens - that are quantified based on H&E stained
images as well as FT-IR images of the tissue samples. By
restricting the features used to geometric measures, we
sought to mimic the pattern recognition process
employed by human experts, and achieve a robust clas-
sification procedure that can produce consistently high
accuracy across independent data sets. We systemati-
cally evaluate the performance of the new method
through cross-validation, and examine its robustness
across data sets. We also summarize the specific mor-
phological features that prove to be most informative in
classification.
Methods
We begin with a description of the computational pipe-
line. As noted above, a key aspect of our approach is
the use of FT-IR imaging data on a serial section that is
H&E-stained to enhance the segmentation of nuclei and
lumens. The first two components of the pipeline are
geared to this functionality, while the next three compo-
nents exploit the segmented features obtained from
image data to classify the tissue sample (Figure 3).
Image Registration
Given two images, the image registration problem can
be defined as finding the optimal spatial and intensity
transformation [41] of one image to the other. Here,
two images are H&E stained (Ireference) and “IR classified”
images (Itarget) which were acquired from adjacent tissue
samples. The IR classified image represents the FT-IR
imaging data, processed as indicated in Figure 2, to clas-
sify each pixel as a particular cell type. Although the
two tissue samples were physically in the same intact
tissue and are structurally similar, the two images have
different properties (total image and pixel sizes, contrast
mechanisms and data values). Hence, features to spa-
tially register the images are not trivial. The H&E image
provides detailed morphological information that could
ordinarily be used for registration, but the IR image
lacks such information. On the other hand, the IR
image specifies the exact areas corresponding to each
cell type, but the difficulty in precisely extracting such
regions from the H&E image hinders us from using cell-
type information for registration. The only obvious fea-
tures are macroscopic tissue sample shape and empty
space (lumens) inside the tissue samples. To utilize
these two features and to avoid problems due to differ-
ences in the two imaging techniques, both images are
first converted into binary images. Due to the binariza-
tion, the intensity transformation is not necessary. As a
spatial transformation, we use an affine transformation
( f ) [41] where a coordinate (x1, y1) is transformed to
the (x2, y2) coordinate after translations (tx, ty), rotation
by θ, and scaling by factor s.
x
y
t
t
s
x
y
x
y
2
2
1
1





 





 
 











cos sin
sin cos


Accordingly, we find the optimal parameters of the
affine transformation that minimizes the absolute
intensity difference between two images (Ireference and
Itarget). In other words, image registration amounts to
finding the optimal parameter values
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downhill simplex method [42] is applied to solve the
above equation. An example of this registration pro-
cess is shown in Figure 4. (See [Additional file 1:
Image Registration] for details.)
Identification of epithelial cells and their morphologic
features
While a number of factors are known to be transformed
in cancerous tissues, epithelial morphology is utilized as
the clinical gold standard. Hence, we focus here on cel-
lular and nuclear morphology of epithelial nuclei and
lumens. These structures are different in normal and
cancerous tissues, but are not widely used in automated
analysis due to a few reasons. First, as described above,
simple detection of epithelium from H&E images is dif-
ficult. Second, detection of epithelial nuclei may be con-
founded by a stromal response that is not uniform for
all grades and types of cancers. We focused first on
addressing these two challenges that hinder automati-
cally parsing morphologic features such as the size and
number of epithelial nuclei and lumens, distance from
nuclei to lumens, geometry of the nuclei and lumens,
and others (Feature Extraction). In order to use these
properties, the first step is to detect nuclei and lumens
correctly and we sought to develop a robust strategy for
the same.
Lumen Detection
In H&E stained images, lumens are recognized to be
empty white spaces surrounded by epithelial cells. In
normal tissues, lumens are larger in diameter and can
have a variety of shapes. In cancerous tissues, lumens
are progressively smaller with increasing grade and gen-
erally have less distorted elliptical or circular shapes.
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are located next to the areas rich in epithelium. White
spots inside the tissue sample can be found from the H&E
image by using a proper threshold value (>200) for the
intensity of Red, Green, and Blue channels, and the pixels
corresponding to epithelial cells can be mapped on the
H&E image from the IR classified image through image
registration. Although restricting the white areas adjacent
to epithelial cells, in our observations, many artifactual
lumens are still present. Additionally, the size and shape of
lumens are examined to eliminate such artifacts. We note
that while lumens are ideally completely surrounded by
epithelial cells (called complete lumens), some tissue sam-
ples have lumens (called incomplete lumens) that violate
this criterion because only a part of lumen is present in
the tissue sample. To identify these incomplete lumens,
we model an entire tissue sample as a circle, and the white
spots between the tissue sample and the circle are the can-
didate incomplete lumens. As did in complete lumen
detection, the same threshold value is used to identify
white areas. To identify artifacts, we use heuristic criteria
based on the size, shape, presence of epithelial cells and
background around the areas. In addition, the distances
from the center of the tissue to the white spots are exam-
ined to identify the artifacts in crescent form which
resulted from the small gaps between the tissue sample
and the circle fitted to the sample. (See [Additional file 1:
Lumen Detection] for details.)
Nucleus Detection - single epithelial cells
Epithelial nucleus detection by automated analysis is
more difficult than lumen detection due to variability in
staining and experimental conditions under which the
entire set of H&E images were acquired. Differences
between normal and canceroust i s s u e s ,a n da m o n gd i f -
ferent grades of cancerous tissues, also hamper facile
detection. To handle such variations and make the con-
trast of the images consistent, we perform smoothing
[43] and adaptive histogram equalization [44] prior to
Figure 3 Overview of System. (a, b) FTIR spectroscopic imaging data-based cell-type classification (IR classified image), is overlaid with H&E
stained image (a), leading to segmentation of nuclei and lumens in a tissue sample (b). (c,d,e) Features are extracted and selected (c), and used
by the classifier (d) to predict (e) whether the sample is cancerous or benign.
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be modeled as small elliptical areas in the stained
images. This geometrical model is often confounded as
multiple nuclei can be so close as to appear like one
large, arbitrary-shaped nucleus. Also, small folds or edge
staining around lumens can make the darker shaded
regions difficult to analyze. Here, we exploit the infor-
mation provided by the IR classified image to limit our-
selves to epithelial cells, and use a thresholding heuristic
on a color space-transformed image to identify nuclei
with high accuracy. Superimposing the IR classified
image on the H&E image, pixels corresponding to
epithelium can be identified on the H&E image. These
epithelial pixels are dominated by one of two colors:
blue or pink, which arise from the nuclear and cytoplas-
mic component respectively. For nuclei restricted to
epithelial cells in this manner, a set of general observa-
tions were made that led us to convert the stained
image to a new image where each pixel has an intensity
value |R + G - B|. (R, G, and B represent the intensity
of Red, Green, and Blue channels, respectively.) This
transformation, followed by suitable thresholding, was
able to successfully characterize the areas where nuclei
are present. The threshold values are adaptively deter-
mined for Red and Green channels due to the variations
in the color intensity. Finally, filling holes and gaps
within nuclei by a morphological closing operation [45],
the segmentation of each nucleus is accomplished by
using a watershed algorithm [45] followed by elimina-
tion of false detections. The size, shape, and average
intensity are considered to identify and remove artifac-
tual nuclei. Figure 5 details the nucleus detection proce-
dure. (See [Additional file 1: Nucleus Detection] for
details.)
Feature Extraction
As mentioned above, the characteristics of nuclei and
lumens change in cancerous tissues. In a normal tissue,
epithelial cells are located mostly in thin layers around
lumens. In cancerous tissue, these cells generally grow
Figure 4 Image Registration. H&E stained images and IR classified images are first converted into binary images. The IR classified image is
overlaid with the H&E stained image by affine transformation, with the optimal matching being found by minimizing the absolute intensity
difference between two images. After registration, original annotations (color and/or cell-type information) of each image are restored.
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lumens, with the shape of lumens becoming more ellip-
tical or circular. The epithelial association with a lumen
becomes inconsistent and epithelial foci may adjoin
lumens or may also exist without an apparent lumen.
Epithelial cells invading the extra-cellular matrix also
result in a deviation from the well-formed lumen struc-
ture; this is well-recognized as a hallmark of cancer.
Due to filling lumen space and invasion into the extra-
cellular space, the number density of epithelial cells
increases in tissue. The size of individual epithelial cells
and their nuclei also tend to increase as malignancy of a
tumor increases. Motivated by such recognized morpho-
logical differences between normal and cancerous tis-
sues, we chose to use epithelial nuclei and lumens as
the basis of the several quantitative features that our
classification system works with. (See examples of such
features in Figure 6.) It is notable that these observa-
tions are qualitative in actual clinical practice and have
not been previously quantified.
Epithelial cell-related features
Epithelial cell information is available from IR data.
However, individual epithelial cells in the tissue are not
easily delineated. Therefore, in addition to features
directly describing epithelial cells, we also quantify prop-
erties of epithelial nuclei, which are available from the
segmentation described above. The quantities we mea-
sure in defining features are: (1) size of epithelial cells,
(2) size of epithelial nuclei, (3) number of nuclei in the
tissue sample, (4) distance from a nucleus to the closest
lumen, (5) distance from a nucleus to the epithelial cell
boundary, (6) number of “isolated” nuclei (nuclei that
have no neighboring nucleus within a certain distance),
(7) number of nuclei located “far” from lumens, and (8)
entropy of spatial distribution of nuclei (Figure 6G).
[Additional file 1: Epithelium-related Features] provide
specifics of these measures and their calculation.
Lumen-related features
Features describing glands have been shown to be effec-
tive in PCa classification [21,25]. Here, we try to charac-
terize lumens and mostly focus on the differences in the
shape of the lumens. The quantities we measure in
defining these features are: (1) size of a lumen, (2) num-
ber of lumens, (3) lumen “roundness” [25], defined as
L
L
r
peri
area 2
where Lperi is the perimeter of the lumen, Larea
is the size of the lumen (i.e., number of pixels in the
Figure 5 Nucleus Detection. Smoothing and adaptive histogram equalization are performed to alleviate variability in H&E stained image and to
obtain better contrast. “RG - B” conversion followed by thresholding characterizes the areas where nuclei exist. Morphological closing operation
is performed to fill holes and gaps within nuclei, and a watershed algorithm segments each individual nuclei. The segmented nuclei are
constrained by their shape, size, and average intensity and epithelial cell classification (green pixels) provided by the overlaid IR image.
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lumen “distortion” (Figure 6A), computed as
STD d
AVG d
L
L
cb
cb
()
()
where dLcb is the distance from the center of a lumen to
the boundary of the lumen and AVG(·) and STD(·) repre-
sent the average and standard deviation, (5) lumen “mini-
mum bounding circle ratio” (Figure 6B), defined as the
ratio of the size of a minimum bounding circle of a
lumen to the size of the lumen, (6) lumen “convex hull
ratio” (Figure 6C), which is the ratio of the size of a con-
vex hull of a lumen to the size of the lumen, (7) sym-
metric index of lumen boundary (Figure 6E, see
[Additional file 1: Lumen-related Features]), (8) sym-
metric index of lumen area (Figure 6F, see [Additional
file 1: Lumen-related Features]), and (9) spatial associa-
tion of lumens and cytoplasm-rich regions (Figure 6D,
see [Additional file 1: Lumen-related Features]). Features
( 3 )-( 8 )a r ev a r i o u sw a y st os u m m a r i z el u m e ns h a p e s ,
Figure 6 Examples Features. Each panel shows one example feature, along with the distributions of the feature’s values for cancer (red) and
benign (blue) classes.
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polarization of epithelial cells in cancerous tissues.
Global & local tissue features
We have described above the individual measures of
epithelium and lumen related quantities that form the
basis of the features used by our classification system.
Normally, these features have to be summary measures
over the entire tissue sample or desired classification
area. Hence, we employ average (AVG) or standard
deviation (STD), and in some cases the sum total (TOT)
of these quantities for further analysis. These features are
called “global” features since they are calculated from the
entire tissue sample. However, in some cases global fea-
tures may be misleading, especially where only a part of
t h et i s s u es a m p l ei si n d i c a t i v eo fc a n c e r .T h e r e f o r e ,i n
addition to global features, we define “local” features by
sliding a rectangular window of a fixed size (100 × 100
pixels) throughout a tissue sample. For each window,
AVG and/or TOT of the epithelium and lumen related
quantities are computed. STD or extremal values (MIN
or MAX) of the AVG and/or TOT values over all win-
dows become local feature values (Figure 7). In all, 67
features (29 global and 38 local features) are defined cap-
turing various aspects of tissue morphology.
Feature Selection
Feature selection is the step where the classifier exam-
ines all available features (67 in our case) with respect
to the training data, and selects a subset to use on test
data. This selection is generally based on the criterion of
high accuracy on training data, but also strives to ensure
generalizability beyond the training data. We adopt a
two-stage feature selection approach here. In the first
stage, we generate a set of candidate features (Ccandidate)
by using the so-called minimum-redundancy-maximal-
relevance (mRMR) criterion [46] (see [Additional file 1:
mRMR]). In each iteration, given a feature set chosen
thus far, mRMR chooses the single additional feature
that is least redundant with the chosen features, while
being highly correlated with the class label. Ccandidate is
a set of features that is expected to be close to the opti-
mal feature set for a data set and a classifier under con-
sideration. It is constructed as follows. Given a feature
set F = (f1, ..., fM) ordered by mRMR, the area under the
ROC curve (AUC) of the set of i top-ranked features is
computed for varying values of i. We limit the value of i
to be ≤ 30. The feature subset with the best AUC is
chosen as the Ccandidate. In the second stage, feature
selection continues with Ccandidate as the starting point,
using the sequential floating forward selection (SFFS)
method [47]. This method sequentially adds new fea-
tures followed by conditional deletion(s) of already
selected features. Starting with the Ccandidate,S F F S
searches for a feature x ∉ Ccandidate that maximizes the
AUC among all feature sets Ccandidate ∪ {x}, and adds it
to Ccandidate.T h e n ,i tf i n d saf e a t u r ex Î Ccandidate that
maximizes the AUC among all feature sets Ccandidate -
{x}. If the removal of x improves the highest AUC
obtained by Ccandidate, x is deleted from Ccandidate.A s
long as this removal improves upon the highest AUC
obtained so far, the removal step is repeated. SFFS
repeats the addition and removal steps until AUC
reaches 1.0 or the number of additions and deletions
exceeds 20, and the feature set with the highest AUC
thus far is chosen as the optimal feature set. The classi-
fication capability of a feature set, required for feature
selection, is measured by AUC, obtained by cross-valida-
tion on the training set. SFFS can be directly applied to
the original feature set; however, using mRMR may help
to reduce the search space and time and to build the
optimal classifier by providing a good initial feature set
for SFFS.
Classification
We note that there are two levels of classification here. In
the first, IR spectral data is used to provide histologic
images where each pixel has been classified as a cell type.
In the second, the measures from H&E images and IR
images are used to classify tissue into disease states. For
the first classification task, we used a Bayesian classifier
built on 18 spectral features. This previously achieved
>0.99 AUC on cell type classification [48,49]. For the latter
task, we used a well established classification algorithm,
Figure 7 Global and Local Feature Extraction. Global features are
extracted from the entire tissue sample, and local features are
extracted by sliding a window of a fixed size across the tissue sample
and computing summary statistics, such as standard deviation, of
window-specific scores. In this example, the global feature “number
of nuclei” has value 755, while one example position of the sliding
window is shown, with “number of nuclei” = 29.
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function, a radial basis function
Kx x x x ij i j ( , ) exp   




 
2
with parameter g =1 0 ,
1, 0.1, 0.01, 0.001 is used. Two cost factors are introduced
to deal with an imbalance in training data [51]. The ratio
between two cost functions was chosen as
C
C



number of negative training examples
number of positive e training examples
to make the potential total cost of the false positives
and the false negatives the same. (See [Additional file 1:
SVM] for details.)
Samples and Data preparation
All of the H&E stained images were acquired on a stan-
dard optical microscope at 40x magnification. The size
of each pixel is 0.9636 um × 0.9636 um. On the other
hand, the pixel size of IR images is 6.25 um × 6.25 um.
Two different tissue microarrays were obtained from
two different sources (Tissue microarray research pro-
gram at the National Institutes of Health and Clinomics
Inc.). The first data set (”Data1“) consisted of 240 tissue
samples from 180 patients, and the second set (”Data2“)
includes 160 tissue samples from 80 patients. Both sets
of tissue samples were sectioned to ~ 7 micron thick
sections, with a section being placed on IR transparent
BaF2 slides and a serial section on a standard glass slide.
The acquisition of data is described elsewhere in [28].
Unfortunately, we were not able to use all of these tissue
samples for several reasons. Each data set has two
TMAs. One is H&E stained image and the other is IR
image. Since these were experimental arrays, some
TMA spots were missing in one or both arrays due to
processing and plating on the salt plates used for IR
analysis. Since our method focuses on epithelial cells,
tissue samples which do not have enough epithelial cells
(>100) in either of two images (H&E and IR) were not
considered in this study. Moreover, some tissue samples
in Data2 are spatially displaced and fused with neigh-
boring tissue samples. Eliminating those tissue samples,
66 benign tissue samples and 115 cancer tissue samples
are remained for Data1, and 14 benign and 36 cancer
tissue samples remained for Data2. An example of H&E
images for both data sets is shown in Figure 8.
Results and discussion
The classification system achieves AUC greater than 0.97
on both data sets
We first performed K-fold cross validation on each data
set. The data set was divided into K roughly equal-sized
partitions, one partition was left out as the “test data”,
the classifier was trained on the union of the remaining
K-1partitions (the “training data”) and evaluated on
the test data. This was repeated K times, with different
choices of the left-out partition. (We set K =1 0 . )I n
each repetition, cross-validation on the training data was
used to select the feature set with the highest AUC as
explained in Feature Selection. The correct and incor-
rect predictions in the test data, across all K repetitions,
were summarized into a ROC plot and the AUC was
computed, along with specificities when sensitivity
equals 90, 95, or 99%. Since the cross-validation exercise
makes random choices in partitioning the data set, we
examined averages of these performance metrics over 10
repeats of the entire cross-validation pipeline. The aver-
age AUC for Data1 and Data2 were 0.982 and 0.974
respectively (Table 1, “feature extraction” = “IR & HE”).
At 90%, 95%, and 99% sensitivities, the average specifi-
city achieved on Data1 was 94.76%, 90.91%, and 77.80%
respectively, while that on Data2 was 92.53%, 84.19%,
and 49.54% respectively. SVM using the kernel para-
meter g = 1 is used here. This result is consistent with
the classification results using different values of the
parameter g (See [Additional file 1: Supplementary
Table S2] for details). We note that other classification
methods can be also used. Among various methods, a
logistic model tree [52], which combines linear logistic
regression with decision tree induction, was used, and
achieved slightly lesser performance than SVM (results
not shown here).
One way to interpret the above values is to examine
our automated pipeline as a pre-screening mechanism
to identify the samples to be examined by a human
pathologist. At a “true positive rate” of 99% (which
means that only 1% of the cancer samples will be missed
by the screen), the “false positive rate” is 22.2% (i.e.,
22.2% of the benign samples will make it through the
Figure 8 H&E images of two data sets.A ne x a m p l eo fH & E
images of (a) Data1 and (b) Data2. Colors in cytoplasmic and
stromal areas are clearly different whereas color of nuclei is less
varied.
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cing the workload of the pathologist by 4.5-fold. While
the error rate of manual pathology determinations is
generally accepted to be in 1-5% range, inclusion of con-
founding cancer mimickers raises the rate to as high as
7.5% [53]. Also noteworthy is the observation that the
same algorithm performs consistently well on both data
sets, that were obtained from different staining condi-
tions. This speaks to the robustness of the classification
framework, an attribute that we investigated further in
the next exercise.
Classification system is robust to staining conditions
Here, we trained a classifier on Data1 and tested its perfor-
mance on Data2 (Table 2, “Data set” = “Test”) using SVM
with g = 1. We observed an average AUC of 0.956, with
average specificity of 88.57%, 81.92%, and 26.86% at sensi-
tivity equaling 90%, 95%, and 99% respectively (Table 2,
“feature extraction” = “IR & HE” and “Data set” = “Test”).
These values are competitive with the cross-validation
results on Data2 (Table 1), where the training and testing
were both performed on (disjoint parts of) Data2.I ts h o u l d
be noted that in Table 2 “Data set” = “Train” means that
the classifier was not only trained but also tested on Data1,
and thus the difference between the “Train” and “Test”
rows does not refer to a difference in performance on the
two data sets. As a classifier is trained on Data2 and tested
on Data1, we obtained the average AUC of 0.855 and aver-
age specificity of 50.18%, 40.41%, and 12.33% at sensitivity
equalling 90%, 95%, and 99% respectively ([Additional file
1: Supplementary Table S4, g = 1]). The results are worse
than both the cross-validation results on Data1 and the
validation results on Data2.T h i sm a yb ed u et ot h ef a c t
that the number of samples in Data2 is relatively small and
much unbalanced. In addition, varying the parameter value
g of SVM, the results, by and large, are the same (See
[Additional file 1: Supplementary Table S3 and S4] for
details).
Use of IR data improves classification performance
To assess the utility of the IR-based cell-type classifica-
tion, we repeated the above exercises after extracting
features without the guidance of the IR data; i.e., epithe-
lial cells were predicted from the H&E images alone
(see [Additional file 1: Epithelium Detection] for details).
All of the features defined in Feature Extraction were
used, except for “Spatial association of lumens and api-
cal regions”, since the distinction between cytoplasm-
rich and nuclear-rich region in epithelial cells was
unclear in H&E images. The results from this disadvan-
taged classifier are shown in Tables 1 and 2 ("feature
extraction” = “HE only”). For both types of experiments,
we obtained lower average AUCs and specificity values.
For instance, the AUC of cross-validation in Data2
(Table 1) dropped from 0.974 to 0.880. Similarly, the
results of validation between data sets (Table 2) were
substantially worse now compared to the IR-guided clas-
sification, with the AUC dropping from 0.956 to 0.918.
We also observed that the average AUC dropped in the
absence of IR data as using different values of parameter
g for SVM (See [Additional file 1] for details). This indi-
cates that the use of IR data, i.e., the improved epithelial
identification, helps to attain better classification perfor-
mance. We also note that other methods, if any, which
Table 1 Classification results via cross-validation
Data
set
Feature
Extraction
AUC Sensitivity
(%)
Specificity
(%)
Mf
AVG STD AVG STD
Data1 IR & HE 0.982 0.0030 90 94.76 1.64 13
95 90.91 1.62
99 77.80 5.52
HE only 0.968 0.0052 90 91.64 2.26 11
95 83.90 1.91
99 53.43 13.65
Data2 IR & HE 0.974 0.0145 90 92.53 7.11 7
95 84.19 10.84
99 49.54 22.51
HE only 0.880 0.0175 90 61.34 10.31 8
95 22.21 10.06
99 11.21 6.01
AVG and STD denote average and standard deviation across ten repeats of
cross-valdiation. Mf is the median size of the feature set obtained by feature
selection from training data. Column “Feature Extraction” indicates if features
were obtained using H&E as well as IR data, or with H&E data alone. The
parameter g of a radial basis kernel for SVM is set to 1.
Table 2 Validation between data sets
Feature
Extraction
Data
set
AUC Sensitivity
(%)
Specificity
(%)
Mf
AVG STD AVG STD
IR & HE Train 0.994 0.0006 90 98.30 0.68 13
95 96.58 1.10
99 91.55 2.55
Test 0.956 0.0089 90 88.57 5.96
95 81.92 5.28
99 26.86 15.50
HE only Train 0.986 0.0021 90 97.77 0.97 10
95 91.56 2.49
99 79.29 4.47
Test 0.918 0.0100 90 65.51 8.37
95 46.14 7.53
99 13.29 6.94
A classifier is trained on Data1 and tested on Data2. AVG and STD denote the
average and standard deviation. Mf is the median size of the optimal feature
set. Column “Feature Extraction” indicates if features were obtained using H&E
as well as IR data, or with H&E data alone. Column “Data set” indicates if the
performance metrics are from training data (Data1) or from test data (Data2).
The parameter g of a radial basis kernel for SVM is set to 1.
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cells may have the same impact with the IR data on the
classification.
Previously, Tabesh et al. achieved an accuracy of 96.7%
via cross validation in cancer/no-cancer classification
[22]. Color, morphometric, and texture features were
extracted, and all images were acquired under similar
conditions. We note that our classification result (Table
1), based solely on morphology, is comparable to their
result; however the software developed by Tabesh et al.
was not available for evaluation in our data sets. Color
and texture features could provide additional informa-
tion; however, their robustness to different data sets is
questionable, and their interpretation is not as obvious as
that of morphological features, which are used in clinical
practice. Different data sets m a yh a v ev a r i e dp r o p e r t i e s
which may be attributable to staining variations, inconsis-
tent image acquisition settings, and image preparation.
The performance of the same method based on texture
features has been seen to greatly change from one data
set to another [19,22,25]. Variations in staining may
affect color features. In contrast, morphological features
were shown to be robust to varying image acquisition
settings [25]. Nonetheless, the quality of morphological
features is subject to segmentation of histologic objects.
Thus, any method based on morphological features will
benefit from the IR cell-type classification.
Examination of discriminative features
We examined the importance of each feature by its rank
in the first phase of feature selection, based on its “rele-
vance” to the class label (see [Additional file 1: mRMR]).
Since different features (e.g., average or standard deviation,
global or local features) based on the same underlying
quantity (e.g., “lumen roundness”) generally have similar
relevance, we examined the average relevance of features
in each of 17 feature categories (Figure 9), for each data
set. The relevance of features is consistent across cross-
validation (see [Additional file 1: Supplementary Figure
S1]). The complete list of the individual features and their
relevance and mRMR rank (for Data1) is available in
Figure 10. For Data1, lumen-related feature categories are
most relevant in general, while epithelium-related feature
categories are most important for Data2. It is surprising
that the top 3 feature categories in Data1 (Figure 9, blue
bars) - size of lumen, lumen roundness, and lumen convex
hull ratio - have very low relevance in Data2, although we
note that this may be in large part due to variations in
staining and malignancy of tumors between the two data
sets and differences in the size of two data sets. The com-
parable classification results on Data2 (Table 1, 2), in spite
of the maximal relevance differences, may indicate the
broadness of our feature set and the accuracy of our fea-
ture selection method and facilitate the application of the
same classifier on different data sets. Nevertheless, a larger
Figure 9 Importance of 17 feature categories. The average “maximal relevance” of features belonging to each feature category is shown, for
both data sets, sorted in decreasing order for the first data set.
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Page 12 of 16Figure 10 List of features and their maximal relevance and “mRMR rank”.I nt h es e c o n dc o l u m n ,G and L represent global and local
features, respectively. AVG, STD, TOT, and MAX denote the average, standard deviation, total amount, and extremal value of features. * In
computing local features representing “size of lumen”, two options are available: one is to consider only the part of the lumen within the
window, and the other is to consider the entire lumen into account. Asterisk indicates that the former option was chosen.
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ferences between data sets and features. It is, however,
noteworthy that examining the features (or feature cate-
gories) with highest relevance alone may be slightly mis-
leading, because this examination does not account for
redundancy among features.
To further examine the most informative and non-
redundant features, we inspected the optimal feature
sets selected after both stages of the feature selection
component. For both Data1 and Data2, the selection of
the features is consistent across all folds of cross valida-
tion. (See [Additional file 1: Supplementary Figure S2]
for details.) In Figure 11, we show an example of three
most frequently selected features for Data1:n u m b e ro f
lumens (LSTD), lumen roundness (GAVG), and size of
nucleus (GTOT). We note that these include both lumen
and epithelium related features. Lumen roundness
(GAVG) is the only one ranked high by maximal rele-
vance (Figure 10), yet all three features are consistently
chosen by the classifier, since they provide different,
complementary information on a tissue: greater circular-
ity of lumens and increase in the number of lumens and
the size of nuclei indicate malignancy of a tissue.
Conclusions
In this manuscript, we have presented a means to elimi-
nate epithelium recognition deficiencies in classifying
H&E images for presence or absence of cancer. The
method is entirely transparent to a user and does not
involve any adjustment or decision-making based on
spectral data. We were able to achieve very effective
fusion of the information from two different modalities,
namely optical and IR microscopy, that provide very dif-
ferent types of data with different characteristics. Several
features of the tissue were quantified and employed for
classification. We found that robust classification could
be achieved using a few measures, which are detailed to
arise from epithelial/lumen organization and provide a
reasonable explanation for the accuracy of the model.
The choice of combining the IR and optical data is
shown to be necessary for achieving the high accuracy
values observed. We anticipate that the combined use of
the two microscopies - structural and chemical - will
lead to an accurate, robust and automated method for
determining cancer within biopsy specimens.
Additional material
Additional file 1: Supplementary material. It includes detailed
description of image processing, feature extraction, feature selection, and
classification method and results.
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